Multiple previous studies on neuroendocrine tumors have confirmed that this type of disease is related to multiple gene mutations/deletions, such as TP53, RB1, CTNNB1, NF1, etc (46–48). This evidence concerns the gene CTNNB1 and neuroendocrine neoplasm.